Jabal Omar Development Company (TADAWUL:4250)

Checkpoint Therapeutics Revenue

Jabal Omar Development Company had revenue of 747.73M SAR in the quarter ending March 31, 2025, with 26.12% growth. This brings the company's revenue in the last twelve months to 2.06B, up 28.32% year-over-year. In the year 2024, Jabal Omar Development Company had annual revenue of 1.90B with 43.32% growth.

• Revenue (ttm): 2.06B
• Revenue Growth: +28.32%
• P/S Ratio: 11.50
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 23.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.90B	574.67M	43.32%
Dec 31, 2023	1.33B	477.22M	56.18%
Dec 31, 2022	849.50M	539.14M	173.72%
Dec 31, 2021	310.36M	133.68M	75.66%
Dec 31, 2020	176.68M	-708.54M	-80.04%